Sonlicromanol

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameSonlicromanol
Drug Alias NameKH-176
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReactive oxygen species modulators
TargetsReactive oxygen species
Therapy Area/IndicationsPost-Acute COVID-19 SyndromeMitochondrial DiseasesDiabetes Mellitus +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesKhondrion Bv
China Registration ClassN/A

Develop Information

Active CompaniesKhondrion Bv
Inactive CompaniesN/A
Active IndicationsPost-Acute COVID-19 SyndromeMitochondrial DiseasesDiabetes Mellitus +[8] 
Inactive IndicationsOptic Atrophy, Hereditary, LeberLeigh DiseaseEncephalomyelitis

Other Information

ATC CodeN/A
Related LinksN/A